Case Reports in Surgery
Volume 2018 (2018), Article ID 9021289, 5 pages
https://doi.org/10.1155/2018/9021289

Case Report

A Case Report of Basal Cell Carcinoma in a Non-Sun-Exposed Area: A Rare Presentation Mimicking Recurrent Perianal Abscess

Audrey V. Carr,¹ Edward Feller,¹ Fouad R. Zakka,² Rogers C. Griffith,² and Steven Schechter³

¹Warren Alpert Medical School of Brown University, Providence, RI, USA
²Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center, Warren Alpert Medical School of Brown University, Providence, RI, USA
³Department of Surgery, Warren Alpert Medical School of Brown University, Providence, RI, USA

Correspondence should be addressed to Audrey V. Carr; audrey_carr@brown.edu

Received 12 September 2018; Accepted 24 October 2018; Published 21 November 2018

Academic Editor: Yehuda Ullmann

Copyright © 2018 Audrey V. Carr et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Basal cell carcinoma (BCC), a common malignancy, arises most often in sun-exposed areas but does rarely occur in non-sun-exposed sites. Prior tissue injury, especially sharp trauma and chronic inflammation, increases the risk of BCC. We describe a 66-year-old male patient with recurrent perianal abscesses who was found to have a large pigmented basal cell carcinoma. The mass was excised without recurrence at two-year follow-up. Perianal BCC is commonly larger at the time of diagnosis than tumors in sun-exposed sites, likely related to delay in diagnosis. Increased size can lead to increased surgical complexity and more pronounced effects on nearby structures. Early detection is important for optimal patient outcomes. In selected patients presenting with a perianal mass, basal cell carcinoma should be included on the differential diagnosis.

1. Introduction

Basal cell carcinoma (BCC) is the most common cutaneous malignancy and accounts for approximately 80% of all nonmelanoma skin cancers [1]. It is estimated that 1 in 5 Americans will have a basal cell carcinoma in their lifetime. Incidence increases with age, sun exposure, and male gender [2]. These tumors typically arise in sun-exposed areas; rarely, they occur in nonexposed areas and have been found on the trunk, genitals, nails, axilla, nipple, or sole of the foot [3, 4]. Rarely, these tumors can occur in the perianal region. Three series including 81 cases of perianal BCC have been reported [5–7], and less than 15 individual case reports have been described in the literature [8–17]. Perianal BCCs are noted to be larger in size than those found in more typical, sun-exposed locations [8, 18].

Once recognized, prognosis is generally good. Treatment with surgical excision is typically curative. Although these cancers rarely metastasize, basal cell carcinoma can invade nearby structures. Therefore, early recognition is critical to optimize outcomes. Here, we describe a case of basal cell carcinoma arising in a non-sun-exposed area to alert clinicians to consider BCC in the differential diagnosis when encountering soft tissue perianal masses.

2. Case Presentation

A 66-year-old male presented with recurrent perianal abscesses over a 12-month period. There was a history of perianal trauma from sitting on broken glass in childhood. Past medical history included vascular dementia, hypertension, hyperlipidemia, atrial fibrillation, and gout. He had no known history of perianal warts, sexually transmitted disease, immune deficiency, inflammatory dermatoses, or arsenic exposure. The patient was a former smoker and had no known family history of malignancy. His primary care physician referred him for ultrasound fine needle aspiration of the abscess, which yielded 15 cc of purulent material (Figure 1). Gram stain and culture were negative for organisms or bacterial growth. Cytology showed atypical squamous cells. Postdrainage differential diagnosis included squamous cell carcinoma, cyst, condyloma, or large abscess.

(a)

(b)

Figure 1: (a) Appearance of the mass at initial presentation. (b) Ultrasound revealed a hyperechoic, well-circumscribed mass.

Because of the presence of atypical squamous cells on cytologic analysis, he was referred to a colorectal surgeon; for unclear reasons, the appointment was delayed for 2 months during which time the mass increased in size, prompting concern for a fistula. Rectal examination again revealed a fluctuant mass in the left lateral quadrant. No fistulas were noted on external exam. The abscess was drained surgically yielding purulent fluid with improvement in the patient’s pain. The culture did not have any microbial growth. A follow-up exam under anesthesia less than one month later revealed an external sinus tract into the mass but no clear fistula to the anal canal. It was decided to excise the mass completely and close the defect primarily (Figure 2).

(a)

(b)

(c)

(d)

Figure 2: (a, b) Mass measured at 4 cm; the medial margin borders of the gluteal cleft. (c, d) The defect is undermined and closed primarily.

Grossly, the specimen consisted of polypoid skin which contained a well-circumscribed tan-grey nodule measuring 3.0 cm in greatest dimension with a central, folded cystic lumen. Microscopically, a nodular well-circumscribed tumor was present in the dermis (Figure 3(a)) and displayed peripheral palisading cells, desmoplastic changes, and retraction artifact. Tumor cells were small, mostly uniform in shape, and hyperchromatic (Figure 3(b)). The tumor produced mucin which was seen as aggregates within the nodules (Figure 3(c)). Foci of dark-brown acellular pigment consisting of coarse clumped granules were found in the lesion (Figures 3(d) and 3(e)), and some tumor nodules displayed a dense fibrous stroma containing pigment clumps and cholesterol clefts.

(a)

(b)

(c)

(d)

(e)

(f)

Figure 3: (a) A nodular, well-circumscribed basophilic tumor involved the dermis and displayed areas of cystic architecture (arrows). (b) The tumor cells were basaloid, small, hyperchromatic, and mostly uniform. Nodules exhibited peripheral palisading cells and retraction artifact (arrows). (c) Islands of mucin (arrows) were present within the tumor. (d) Some tumor nodules exhibited dark-brown pigment centrally. (e) The pigment was coarse and acellular. (f) Desmoplastic stroma harboring cholesterol clefts (arrows) and clumps of pigment was seen in nodule centers. (a–f) Hematoxylin and eosin: (a) 20x, (b) 40x, (c) 100x, (d) 40x, (e) 200x, and (f) 100x.

Immunohistochemical studies demonstrated tumor cell positivity for cytokeratin 7 (CK7), high molecular weight keratin (CK903), and Ber-EP4. Patchy or focal positivity was observed with cytokeratin CAM 5.2 and epithelial membrane antigen (EMA). Focal melan-A-positive cells were thought to represent benign melanocytes that colonized the tumor. The tumor was negative for melanoma antigen (HMB45) and microphthalmia transcription factor (MITF). The surgical margins were more than 1 mm away from the nearest tumor border.

At one-month follow-up, the wound had completely healed. No further adjuvant therapy was performed except periodic surveillance to evaluate for recurrence, as well as dermatologic surveillance to assess for basal cell carcinomas elsewhere. At two-year follow-up evaluation, there had been no recurrence or complications (Figure 4).

Figure 4: Healed incision site at 10 months postoperatively.

3. Discussion

Basal cell carcinoma can have diverse histological features, including the presence of pigment and mucin, as seen in this case [19]. Pigmented BCC is a rare clinical and pathological variant which comprises about 6% of total BCCs [20]. Fewer than 100 cases of BCC on the perianal and genital skin have been reported, mainly as individual case reports or small case series [5–17]. In a review of 51 patients, the most common anatomic site was close to the anal orifice, although some reported cases arose from or extended into the anal canal or buttocks as in our patient [5]. The natural history of perianal BCC does not appear to differ from BCC in other locations, although they are typically larger than BCC in other sites, which may be due to delay in diagnosis. When basal cell tumors were originally documented in the perianal area, they were thought to be more aggressive than BCC in other locations; however, this has not been seen in later case reports [6].

Areas of chronic irritation and areas of scar are more likely to develop both squamous cell carcinoma (SCC) and BCC than other healthy tissues [18, 21]. A review of over 1000 cases of carcinomas arising in scar tissue found that 71% of cases were SCC and 12% were BCC [21]. The mean latency from injury to BCC malignancy was 19 years (standard deviation: 22 years). There have also been case reports of carcinoma arising in perianal fistulas, although the majority were rectal adenocarcinomas and the remaining were SCC [22]. It is theorized that scar tissue may lack typical lymphatic channels and therefore these areas do not receive routine surveillance by immune cells, making aberrant cells less likely to be recognized [21]. Human papilloma virus does not appear to be involved in BCC pathogenesis, unlike well-studied associations seen with SCC [5, 23].

Delay in diagnosis is common and likely due to multiple factors, including (1) patient delay in presentation for what they might consider trivial irritation; (2) misdiagnosis of BCC for inflammatory, allergic, or infectious skin lesions; (3) rarity of BCC is sun-protected areas; (4) diversity of macroscopic appearance, ranging from erythematous papules and patches to nodules, plaques, and ulcers, mimicking other more common perianal lesions in the differential diagnoses of a perianal mass (Table 1); and (5) in dark-skinned people, BCC may be pigmented and mistaken for malignant melanoma.

Table 1: Differential diagnosis of a perianal mass.

Acrochordon (skin tag)
Kaposi’s sarcoma

Basal cell carcinoma
Malignant melanoma

Condylomata acuminata
Perianal abscess/fistula

Crohn’s disease
Pilonidal cyst/abscess

Cutaneous tuberculosis
Squamous cell carcinoma/Bowen’s disease

Epidermoid cyst
Thrombosed external hemorrhoid

Hidradenitis suppurativa
Perianal basaloid (cloacogenic) squamous cell carcinoma

At diagnosis, a total body skin exam should be performed to evaluate for BCC in other locations. Treatment is wide local excision. Tumors arising in areas of prior injury are likely to require complex surgical excision. One analysis found that patients with BCC arising in areas of prior trauma were more likely to require 5 or more stages of Mohs surgery when compared to those BCC related to sun exposure [18]. This difference may be related to increased tissue complexity in already damaged tissue, larger size, or diagnostic delay in some patients. In as many as 95% of cases, local excision is curative and local recurrence is uncommon [5, 6]. Two case reports also reported successful treatment with radiotherapy for patients considered to be poor surgical candidates [10, 12]. Long-term follow-up includes monitoring for BCC in other sites, as patients who have had one BCC may have as much as a 50% risk of developing a second primary BCC within 5 years [24]. However, it is not known if this risk is the same for patients with trauma-related BCC as those with tumors in sun-exposed areas.

Caution should be exercised when assessing prior literature. The bulk of the published experience with perianal BCC consists of case reports or small case series, prone to publication bias favoring unusual, atypical cases that may not reflect actual clinical practice or contemporary reporting and follow-up.

Clinicians must be aware that any chronic buttock lesion, whether arising de novo or due to radiation, hidradenitis suppurativa, burns, and trauma (such as sharp injury from glass, as in our patient) can be associated with indolent chronic inflammation and be a precursor to BCC.

Conflicts of Interest

The authors declare that there is no conflict of interest regarding the publication of this article.

References

H. W. Rogers, M. A. Weinstock, S. R. Feldman, and B. M. Coldiron, “Incidence estimate of nonmelanoma skin cancer (keratinocyte carcinomas) in the US population, 2012,” JAMA Dermatology, vol. 151, no. 10, pp. 1081–1086, 2015.

A. G. Marzuka and S. E. Book, “Basal cell carcinoma: pathogenesis, epidemiology, clinical features, diagnosis, histopathology, and management,” The Yale Journal of Biology and Medicine, vol. 88, no. 2, pp. 167–179, 2015.

R. Betti, C. Bruscagin, E. Inselvini, and C. Crosti, “Basal cell carcinomas of covered and unusual sites of the body,” International Journal of Dermatology, vol. 36, no. 7, pp. 503–505, 1997.

M. J. Roth, J. B. Stern, H. M. Haupt, R. R. L. Smith, and S. J. Berlin, “Basal cell carcinoma of the sole,” Journal of Cutaneous Pathology, vol. 22, no. 4, pp. 349–353, 1995.

G. E. Gibson and I. Ahmed, “Perianal and genital basal cell carcinoma: a clinicopathologic review of 51 cases,” Journal of the American Academy of Dermatology, vol. 45, no. 1, pp. 68–71, 2001.

C. A. Paterson, T. M. Young-Fadok, and R. R. Dozois, “Basal cell carcinoma of the perianal region: 20-year experience,” Diseases of the Colon and Rectum, vol. 42, no. 9, pp. 1200–1202, 1999.

D. T. Patil, J. R. Goldblum, and S. D. Billings, “Clinicopathological analysis of basal cell carcinoma of the anal region and its distinction from basaloid squamous cell carcinoma,” Modern Pathology, vol. 26, no. 10, pp. 1382–1389, 2013.

A. M. Salih, F. H. Kakamad, and G. M. Rauf, “Basal cell carcinoma mimicking pilonidal sinus: a case report with literature review,” International Journal of Surgery Case Reports, vol. 28, pp. 121–123, 2016.

D. V. Nagendra Naidu and V. Rajakumar, “Perianal basal cell carcinoma-an unusual site of occurrence,” Indian Journal of Dermatology, vol. 55, no. 2, pp. 178–180, 2010.

H. S. Lee and S. K. Kim, “Basal cell carcinoma presenting as a perianal ulcer and treated with radiotherapy,” Annals of Dermatology, vol. 27, no. 2, pp. 212–214, 2015.

A. España, P. Redondo, M. A. Idoate, M. J. Serna, and E. Quintanilla, “Perianal basal cell carcinoma,” Clinical and Experimental Dermatology, vol. 17, no. 5, pp. 360–362, 1992.

Ş. Yaşar, B. Yaşar, T. Doruk, E. Abut, and Z. Aşi̇ran Serdar, “Giant perianal basal cell carcinoma: an uncommon localization: case report,” Turkiye Klinikleri Journal of Medical Sciences, vol. 32, no. 6, pp. 1710–1713, 2012.

J. P. Rivera-Chavarría, F. Vargas-Villalobos, and S. Riggioni-Víquez, “Bilateral V-Y flap for a perianal basal cell carcinoma: a case report,” International Journal of Surgery Case Reports, vol. 24, pp. 153–155, 2016.

M. W. Meeks, S. Grace, G. Montenegro et al., “Perianal basal cell carcinoma: a case report,” Journal of Gastrointestinal Cancer, 2018.

N. Misago and Y. Narisawa, “Polypoid basal cell carcinoma on the perianal region: a case report and review of the literature,” The Journal of Dermatology, vol. 31, no. 1, pp. 51–55, 2004.

E. W. Kraus, “Perianal basal cell carcinoma,” Archives of Dermatology, vol. 114, no. 3, pp. 460-461, 1978.

D. C. Damin, M. A. Rosito, P. Gus et al., “Perianal basal cell carcinoma,” Journal of Cutaneous Medicine and Surgery, vol. 6, no. 1, pp. 26–28, 2002.

F. R. Noodleman and S. V. Pollack, “Trauma as a possible etiologic factor in basal cell carcinoma,” The Journal of Dermatologic Surgery and Oncology, vol. 12, no. 8, pp. 841–846, 1986.

T. R. Wade and A. B. Ackerman, “The many faces of basal-cell carcinoma,” Dermatologic Surgery, vol. 4, no. 1, pp. 23–28, 1978.

M. E. Maloney, D. B. Jones, and F. Mack Sexton, “Pigmented basal cell carcinoma: investigation of 70 cases,” Journal of the American Academy of Dermatology, vol. 27, no. 1, pp. 74–78, 1992.

A. Kowal-Vern and B. K. Criswell, “Burn scar neoplasms: a literature review and statistical analysis,” Burns, vol. 31, no. 4, pp. 403–413, 2005.

R. L. Nelson, M. L. Prasad, and H. Abcarian, “Anal carcinoma presenting as a perirectal abscess or fistula,” Archives of Surgery, vol. 120, no. 5, pp. 632–635, 1985.

S. Ljubojevic and M. Skerlev, “HPV-associated diseases,” Clinics in Dermatology, vol. 32, no. 2, pp. 227–234, 2014.

N. M. Mc Loone, J. Tolland, M. Walsh, and O. M. Dolan, “Follow-up of basal cell carcinomas: an audit of current practice,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 6, pp. 698–701, 2006.